Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
GP96 is a GARP chaperone and controls regulatory T cell functions
Yongliang Zhang, … , Bei Liu, Zihai Li
Yongliang Zhang, … , Bei Liu, Zihai Li
Published January 20, 2015
Citation Information: J Clin Invest. 2015;125(2):859-869. https://doi.org/10.1172/JCI79014.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 1

GP96 is a GARP chaperone and controls regulatory T cell functions

  • Text
  • PDF
Abstract

Molecular chaperones control a multitude of cellular functions via folding chaperone-specific client proteins. CD4+FOXP3+ Tregs play key roles in maintaining peripheral tolerance, which is subject to regulation by multiple molecular switches, including mTOR and hypoxia-inducible factor. It is not clear whether GP96 (also known as GRP94), which is a master TLR and integrin chaperone, controls Treg function. Using murine genetic models, we demonstrated that GP96 is required for Treg maintenance and function, as loss of GP96 resulted in instability of the Treg lineage and impairment of suppressive functions in vivo. In the absence of GP96, Tregs were unable to maintain FOXP3 expression levels, resulting in systemic accumulation of pathogenic IFN-γ–producing and IL-17–producing T cells. We determined that GP96 serves as an essential chaperone for the cell-surface protein glycoprotein A repetitions predominant (GARP), which is a docking receptor for latent membrane–associated TGF-β (mLTGF-β). The loss of both GARP and integrins on GP96-deficient Tregs prevented expression of mLTGF-β and resulted in inefficient production of active TGF-β. Our work demonstrates that GP96 regulates multiple facets of Treg biology, thereby placing Treg stability and immunosuppressive functions strategically under the control of a major stress chaperone.

Authors

Yongliang Zhang, Bill X. Wu, Alessandra Metelli, Jessica E. Thaxton, Feng Hong, Saleh Rachidi, Ephraim Ansa-Addo, Shaoli Sun, Chenthamarakshan Vasu, Yi Yang, Bei Liu, Zihai Li

×

Figure 7

GP96 is a critical chaperone for cell-surface expression of GARP and mLTGF-β.

Options: View larger image (or click on image) Download as PowerPoint
GP96 is a critical chaperone for cell-surface expression of GARP and mLT...
(A) Flow cytometry analysis of GARP and mLTGF-β expression on CD4+FOXP3+ Tregs from the thymus and spleen either immediately after isolation or after anti-CD3 and anti-CD28 antibody treatment for 24 hours. (B) Flow cytometry analysis of GARP and mLTGF-β expression on CD41+ platelets. Two experiments were performed with similar findings. (C) Surface expression of GARP or IC GARP (solid line, open histogram) was analyzed in WT and GP96-deficient cells transduced with GARP-FLAG. Gray histograms represent isotype controls. Data from A and C represent 4 independent experiments. (D) Immunoblot of GP96 and GARP-FLAG following immunoprecipitation with GP96 antibody (left) or FLAG antibody (right) from GARP-FLAG–overexpressed cell lysates. Data represent 4 independent experiments. (E) The sensitivity of GARP to N-glycase Endo H and PNGase F in WT and GP96 mutant cells. Data are representative of 2 independent experiments. (F) GP96 mutant cells were transduced with full-length GP96 or CBD-deleted GP96 (ΔCBD), followed by examination of cell-surface and IC GARP. Data represent 3 independent experiments. (G) Half-life analysis of GARP-FLAG by immunoblot in WT and GP96-deficient cells following cycloheximide (CHX) treatment. Graph represents densitometric value of the full-length GARP, with time 0 set at 100%. Data represent 2 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
66 readers on Mendeley
See more details